• Will Rising Health Awareness Drive India’s Herbal Medicine Market at an 8.0% CAGR?
    According to a new report from Intel Market Research, the India herbal medicine market was valued at USD 4.56 billion in 2026 and is projected to reach USD 7.23 billion by 2034, growing at a steady CAGR of 8.0% during the forecast period (2026-2034). This growth reflects the country's increasingly health-conscious population and expanding government support for traditional medicine systems.
    https://www.intelmarketresearch.com/download-sample/10362/global-india-herbal-medicine-forecast-2025-2032-126
    Will Rising Health Awareness Drive India’s Herbal Medicine Market at an 8.0% CAGR? According to a new report from Intel Market Research, the India herbal medicine market was valued at USD 4.56 billion in 2026 and is projected to reach USD 7.23 billion by 2034, growing at a steady CAGR of 8.0% during the forecast period (2026-2034). This growth reflects the country's increasingly health-conscious population and expanding government support for traditional medicine systems. https://www.intelmarketresearch.com/download-sample/10362/global-india-herbal-medicine-forecast-2025-2032-126
    Download Free Sample : Herbal Medicine Market
    Free Sample Report Preview: India Herbal Medicine Market, Outlook and Forecast 2025-2032
    0 Comments 0 Shares 7 Views 0 Reviews
  • Top 10 Key Players Transforming the Hemostatic Agents Market (2025–2032)

    According to a newly published market research report by 24LifeSciences, global hemostatic agents market was valued at USD 3.65 billion in 2024 and is projected to reach USD 5.88 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 2025-2032.

    Hemostatic agents are critical medical products used as an adjunct or alternative to standard suturing and cauterization techniques to control bleeding during surgical procedures and in trauma care. These agents work by promoting rapid clot formation at the site of bleeding and include product segments such as gelatin sponges, oxidized regenerated cellulose based hemostats, collagen-based agents, and combination hemostats. Their established efficacy in achieving hemostasis continues to underpin their essential role across various surgical specialties, including cardiovascular, orthopedic, and emergency medicine.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/1056/hemostatic-agents-market-market
    Top 10 Key Players Transforming the Hemostatic Agents Market (2025–2032) According to a newly published market research report by 24LifeSciences, global hemostatic agents market was valued at USD 3.65 billion in 2024 and is projected to reach USD 5.88 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 2025-2032. Hemostatic agents are critical medical products used as an adjunct or alternative to standard suturing and cauterization techniques to control bleeding during surgical procedures and in trauma care. These agents work by promoting rapid clot formation at the site of bleeding and include product segments such as gelatin sponges, oxidized regenerated cellulose based hemostats, collagen-based agents, and combination hemostats. Their established efficacy in achieving hemostasis continues to underpin their essential role across various surgical specialties, including cardiovascular, orthopedic, and emergency medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/1056/hemostatic-agents-market-market
    0 Comments 0 Shares 10 Views 0 Reviews
  • Enteral Medicine Straw Market Size to Reach USD 5.8 Million by 2034 | Trends & Forecasts

    According to a newly published market research report by 24LifeSciences, global enteral medicine straw market was valued at USD 4.2 million in 2024 and is projected to reach USD 5.8 million by 2032, growing at a compound annual growth rate (CAGR) of 4.1% during the forecast period 2025–2032.

    Enteral medicine straws are specialized medical devices designed for the safe and accurate oral administration of liquid or powdered medication to patients with dysphagia or those reliant on enteral feeding tubes. These single-use, calibrated straws are critical for ensuring precise dosing, preventing tube occlusions, and minimizing contamination risks in both clinical and homecare settings. Their role in facilitating effective medication delivery for vulnerable patient populations underpins their essential position in supportive care management.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10708/enteral-medise-straw-market
    Enteral Medicine Straw Market Size to Reach USD 5.8 Million by 2034 | Trends & Forecasts According to a newly published market research report by 24LifeSciences, global enteral medicine straw market was valued at USD 4.2 million in 2024 and is projected to reach USD 5.8 million by 2032, growing at a compound annual growth rate (CAGR) of 4.1% during the forecast period 2025–2032. Enteral medicine straws are specialized medical devices designed for the safe and accurate oral administration of liquid or powdered medication to patients with dysphagia or those reliant on enteral feeding tubes. These single-use, calibrated straws are critical for ensuring precise dosing, preventing tube occlusions, and minimizing contamination risks in both clinical and homecare settings. Their role in facilitating effective medication delivery for vulnerable patient populations underpins their essential position in supportive care management. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10708/enteral-medise-straw-market
    0 Comments 0 Shares 33 Views 0 Reviews
  • Oligonucleotide CDMO Market’s CAGR of 8.9%: Key Players

    According to a newly published market research report by 24LifeSciences, global oligonucleotide process development and manufacturing market was valued at USD 1.14 billion in 2024 and is projected to reach USD 2.04 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2025-2031.

    Oligonucleotides, which are short, single-stranded DNA or RNA molecules typically consisting of 20 to 30 nucleotides, play crucial roles in antisense therapy, gene silencing, and as primers or probes in molecular biology. The manufacturing process involves sophisticated techniques including solid-phase synthesis using phosphoramidite chemistry, followed by deprotection, cleavage, purification (typically using reverse-phase HPLC), and rigorous quality control analysis to ensure high purity and correct sequence integrity. These precision molecules continue to underpin the advancement of nucleic acid therapeutics and personalized medicine approaches.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5182/oligonucleotide-process-development-and-manufacturing-market
    Oligonucleotide CDMO Market’s CAGR of 8.9%: Key Players According to a newly published market research report by 24LifeSciences, global oligonucleotide process development and manufacturing market was valued at USD 1.14 billion in 2024 and is projected to reach USD 2.04 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2025-2031. Oligonucleotides, which are short, single-stranded DNA or RNA molecules typically consisting of 20 to 30 nucleotides, play crucial roles in antisense therapy, gene silencing, and as primers or probes in molecular biology. The manufacturing process involves sophisticated techniques including solid-phase synthesis using phosphoramidite chemistry, followed by deprotection, cleavage, purification (typically using reverse-phase HPLC), and rigorous quality control analysis to ensure high purity and correct sequence integrity. These precision molecules continue to underpin the advancement of nucleic acid therapeutics and personalized medicine approaches. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5182/oligonucleotide-process-development-and-manufacturing-market
    0 Comments 0 Shares 19 Views 0 Reviews
  • 3D Printed Medical Silicone Vasculature Market Outlook 2026

    According to a newly published market research report by 24LifeSciences, global 3D Printed Medical Silicone Vasculature market was valued at USD 27.2 million in 2024 and is projected to reach USD 74.7 million by 2031, growing at a compound annual growth rate (CAGR) of 15.7% during the forecast period 2025-2031.

    3D Printed Medical Silicone Vasculature refers to biocompatible, flexible vascular structures manufactured using additive manufacturing techniques that replicate the mechanical and biological properties of natural blood vessels. These advanced biomimetic structures enable breakthroughs in surgical training, drug testing platforms, and organ replacement research, representing a significant advancement in regenerative medicine and personalized healthcare solutions.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5258/d-printed-medical-silicone-vasculature-market
    3D Printed Medical Silicone Vasculature Market Outlook 2026 According to a newly published market research report by 24LifeSciences, global 3D Printed Medical Silicone Vasculature market was valued at USD 27.2 million in 2024 and is projected to reach USD 74.7 million by 2031, growing at a compound annual growth rate (CAGR) of 15.7% during the forecast period 2025-2031. 3D Printed Medical Silicone Vasculature refers to biocompatible, flexible vascular structures manufactured using additive manufacturing techniques that replicate the mechanical and biological properties of natural blood vessels. These advanced biomimetic structures enable breakthroughs in surgical training, drug testing platforms, and organ replacement research, representing a significant advancement in regenerative medicine and personalized healthcare solutions. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5258/d-printed-medical-silicone-vasculature-market
    0 Comments 0 Shares 39 Views 0 Reviews
  • Nano Healthcare Tech for Medical Equipment Market to Reach USD 13 Billion by 2034

    According to a newly published market research report by 24LifeSciences, global Nano Healthcare Technology for Medical Equipment market was valued at USD 7.84 billion in 2024 and is projected to reach USD 13.23 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.0% during the forecast period 2025-2031.

    Nano healthcare technology involves the application of nanoscale materials and devices in medicine, revolutionizing disease diagnosis, treatment, and monitoring. These technologies enable the development of highly sensitive diagnostic devices, advanced imaging systems, and targeted therapeutic delivery platforms. Key applications include biochips, implantable materials, medical textiles, wound dressings, and active implantable devices, all leveraging the unique properties of nanomaterials to enhance functionality, precision, and patient outcomes in modern healthcare.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8934/nano-healthcare-technology-for-medical-equipment-market
    Nano Healthcare Tech for Medical Equipment Market to Reach USD 13 Billion by 2034 According to a newly published market research report by 24LifeSciences, global Nano Healthcare Technology for Medical Equipment market was valued at USD 7.84 billion in 2024 and is projected to reach USD 13.23 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.0% during the forecast period 2025-2031. Nano healthcare technology involves the application of nanoscale materials and devices in medicine, revolutionizing disease diagnosis, treatment, and monitoring. These technologies enable the development of highly sensitive diagnostic devices, advanced imaging systems, and targeted therapeutic delivery platforms. Key applications include biochips, implantable materials, medical textiles, wound dressings, and active implantable devices, all leveraging the unique properties of nanomaterials to enhance functionality, precision, and patient outcomes in modern healthcare. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8934/nano-healthcare-technology-for-medical-equipment-market
    0 Comments 0 Shares 73 Views 0 Reviews
  • Thoracic Catheters Market to Reach USD 592 Million by 2034 | Growth Insights

    According to a newly published market research report by 24LifeSciences, global thoracic catheters market was valued at USD 375 million in 2025 and is projected to grow from USD 400 million in 2026 to reach USD 592 million by 2034, growing at a compound annual growth rate (CAGR) of 6.9% during the forecast period.

    Thoracic catheters, clinically known as chest tubes or intercostal drainage catheters, are indispensable medical devices used to drain air, blood, fluid, or pus from the pleural space. Their core function is to restore negative intrapleural pressure, allowing the lung to re-expand following conditions like pneumothorax, hemothorax, pleural effusion, or post-operative drainage. These procedures are fundamental in thoracic surgery, pulmonology, emergency medicine, and critical care, making thoracic catheters a cornerstone of life-saving interventions worldwide.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7653/thoracic-catheters-market
    Thoracic Catheters Market to Reach USD 592 Million by 2034 | Growth Insights According to a newly published market research report by 24LifeSciences, global thoracic catheters market was valued at USD 375 million in 2025 and is projected to grow from USD 400 million in 2026 to reach USD 592 million by 2034, growing at a compound annual growth rate (CAGR) of 6.9% during the forecast period. Thoracic catheters, clinically known as chest tubes or intercostal drainage catheters, are indispensable medical devices used to drain air, blood, fluid, or pus from the pleural space. Their core function is to restore negative intrapleural pressure, allowing the lung to re-expand following conditions like pneumothorax, hemothorax, pleural effusion, or post-operative drainage. These procedures are fundamental in thoracic surgery, pulmonology, emergency medicine, and critical care, making thoracic catheters a cornerstone of life-saving interventions worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7653/thoracic-catheters-market
    0 Comments 0 Shares 37 Views 0 Reviews
  • Intracranial Stents Market Outlook 2026: Size, Trends & Key Players

    According to a newly published market research report by 24LifeSciences, global intracranial stents market was valued at USD 222 million in 2025 and is projected to grow from USD 234 million in 2026 to reach USD 284 million by 2034, growing at a compound annual growth rate (CAGR) of 3.7% during the forecast period.

    Intracranial stents are highly specialized tubular medical devices engineered for precise placement within the delicate blood vessels of the intracranial cavity to treat complex vascular abnormalities. Unlike conventional stents used in other parts of the body, these devices are meticulously designed for neurological applications, primarily to manage life-threatening cerebrovascular conditions such as ischemic and hemorrhagic strokes. By reinforcing weakened arterial walls and re-establishing proper blood flow, these stents play a critical role in preventing aneurysm rupture and reducing the recurrence of strokes, making them indispensable in modern neuro-interventional medicine.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download sample/1715/intracranial-stents-market
    Intracranial Stents Market Outlook 2026: Size, Trends & Key Players According to a newly published market research report by 24LifeSciences, global intracranial stents market was valued at USD 222 million in 2025 and is projected to grow from USD 234 million in 2026 to reach USD 284 million by 2034, growing at a compound annual growth rate (CAGR) of 3.7% during the forecast period. Intracranial stents are highly specialized tubular medical devices engineered for precise placement within the delicate blood vessels of the intracranial cavity to treat complex vascular abnormalities. Unlike conventional stents used in other parts of the body, these devices are meticulously designed for neurological applications, primarily to manage life-threatening cerebrovascular conditions such as ischemic and hemorrhagic strokes. By reinforcing weakened arterial walls and re-establishing proper blood flow, these stents play a critical role in preventing aneurysm rupture and reducing the recurrence of strokes, making them indispensable in modern neuro-interventional medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download sample/1715/intracranial-stents-market
    0 Comments 0 Shares 36 Views 0 Reviews
  • Top 10 Companies Driving Innovation in the Airway Management Devices Market

    According to a newly published market research report by 24LifeSciences, global airway management devices market was valued at USD 1.165 billion in 2025 and is projected to grow from USD 1.17 billion in 2026 to reach USD 1.556 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period.

    Airway management devices are critical medical instruments used to maintain or restore a patient's airway patency, ensuring adequate ventilation and oxygenation when the natural airway is compromised. This category includes essential devices such as endotracheal tubes (ETTs), which are inserted into the trachea, and laryngeal mask airways (LMAs), which sit in the hypopharynx. Other crucial devices in this segment are Guedel airways and tracheostomy tubes. Their established role in securing the airway during surgery, emergency care, and critical illness continues to underpin their fundamental importance in anesthesiology, emergency medicine, and intensive care.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/801/airway-management-devices-market
    Top 10 Companies Driving Innovation in the Airway Management Devices Market According to a newly published market research report by 24LifeSciences, global airway management devices market was valued at USD 1.165 billion in 2025 and is projected to grow from USD 1.17 billion in 2026 to reach USD 1.556 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period. Airway management devices are critical medical instruments used to maintain or restore a patient's airway patency, ensuring adequate ventilation and oxygenation when the natural airway is compromised. This category includes essential devices such as endotracheal tubes (ETTs), which are inserted into the trachea, and laryngeal mask airways (LMAs), which sit in the hypopharynx. Other crucial devices in this segment are Guedel airways and tracheostomy tubes. Their established role in securing the airway during surgery, emergency care, and critical illness continues to underpin their fundamental importance in anesthesiology, emergency medicine, and intensive care. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/801/airway-management-devices-market
    0 Comments 0 Shares 19 Views 0 Reviews
  • Stem Cell Banking Market Growth Analysis: Opportunities & Forecasts

    According to a newly published market research report by 24LifeSciences, global stem cell banking market was valued at USD 1,761 Million in 2025 and is projected to grow from USD 1,896 million in 2026 to reach USD 2,943 Million by 2034, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period.

    Stem cell banking is the process of collecting, processing, and cryogenically preserving stem cells from sources like umbilical cord blood, cord tissue, and adult tissues for potential future therapeutic use. This service, often termed a biological insurance policy, plays an increasingly crucial role in regenerative medicine, offering potential treatments for a wide array of conditions from blood cancers like leukemia and lymphoma to genetic disorders and potential future applications in neurological and autoimmune diseases. Its importance is underscored by the growing arsenal of stem cell-based therapies entering clinical practice.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4282/stem-cell-banking-market-market
    Stem Cell Banking Market Growth Analysis: Opportunities & Forecasts According to a newly published market research report by 24LifeSciences, global stem cell banking market was valued at USD 1,761 Million in 2025 and is projected to grow from USD 1,896 million in 2026 to reach USD 2,943 Million by 2034, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period. Stem cell banking is the process of collecting, processing, and cryogenically preserving stem cells from sources like umbilical cord blood, cord tissue, and adult tissues for potential future therapeutic use. This service, often termed a biological insurance policy, plays an increasingly crucial role in regenerative medicine, offering potential treatments for a wide array of conditions from blood cancers like leukemia and lymphoma to genetic disorders and potential future applications in neurological and autoimmune diseases. Its importance is underscored by the growing arsenal of stem cell-based therapies entering clinical practice. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4282/stem-cell-banking-market-market
    0 Comments 0 Shares 35 Views 0 Reviews
  • Pharmaceutical E-commerce Market Outlook 2026: Size, Trends & Key Players

    According to a newly published market research report by 24LifeSciences, global pharmaceutical e-commerce market is valued at USD 75.2 billion in 2026 and is projected to reach USD 185.5 billion by 2034, growing at a compound annual growth rate (CAGR) of 11.8% during the forecast period.

    Pharmaceutical e-commerce refers to the online sale and distribution of prescription medicines, over-the-counter (OTC) products, health supplements, and wellness items through digital platforms. This transformative channel facilitates transactions between pharmacies, distributors, and consumers via websites and mobile applications, encompassing both business-to-consumer (B2C) and business-to-business (B2B) models. The integration of telemedicine services for electronic prescription fulfillment is revolutionizing how patients access chronic and acute medications, offering unprecedented convenience and accessibility.

    Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10357/pharmaceutical-e-commerce-market
    Pharmaceutical E-commerce Market Outlook 2026: Size, Trends & Key Players According to a newly published market research report by 24LifeSciences, global pharmaceutical e-commerce market is valued at USD 75.2 billion in 2026 and is projected to reach USD 185.5 billion by 2034, growing at a compound annual growth rate (CAGR) of 11.8% during the forecast period. Pharmaceutical e-commerce refers to the online sale and distribution of prescription medicines, over-the-counter (OTC) products, health supplements, and wellness items through digital platforms. This transformative channel facilitates transactions between pharmacies, distributors, and consumers via websites and mobile applications, encompassing both business-to-consumer (B2C) and business-to-business (B2B) models. The integration of telemedicine services for electronic prescription fulfillment is revolutionizing how patients access chronic and acute medications, offering unprecedented convenience and accessibility. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10357/pharmaceutical-e-commerce-market
    0 Comments 0 Shares 55 Views 0 Reviews
  • What Precision Medicine Expands Global 4-Fluorophenylacetic Acid Targeted Therapies?

    4-Fluorophenylacetic acid serves as a critical building block in synthesizing various pharmaceuticals, agrochemicals, and advanced materials. Its unique molecular structure enables selective fluorination, which pharmaceutical companies leverage to enhance drug efficacy and metabolic stability. As regulatory pressures mount for safer, more effective medications, demand for this specialty intermediate continues its upward trajectory.

    Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/281887/global-fluorophenylacetic-acid-market-2024-261
    What Precision Medicine Expands Global 4-Fluorophenylacetic Acid Targeted Therapies? 4-Fluorophenylacetic acid serves as a critical building block in synthesizing various pharmaceuticals, agrochemicals, and advanced materials. Its unique molecular structure enables selective fluorination, which pharmaceutical companies leverage to enhance drug efficacy and metabolic stability. As regulatory pressures mount for safer, more effective medications, demand for this specialty intermediate continues its upward trajectory. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/281887/global-fluorophenylacetic-acid-market-2024-261
    Sample Report: Global 4-fluorophenylacetic Acid Market Research Report 2026(Status and Outlook)
    Download Sample Report PDF : Global 4-fluorophenylacetic Acid market was valued at USD 102.3M in 2024 and is projected to reach USD 142.3M by 2030, at 5.6% CAGR.
    0 Comments 0 Shares 51 Views 0 Reviews
More Results